{
  "id": 15971399,
  "title": "J.Jill EVP, CFO & COO Mark Webb sells $122,600 in shares",
  "url": "https://urgent.news/2026/10/21/j-jill-evp-cfo-coo-mark-webb-sells-122-600-in-shares",
  "topic": "finance",
  "section": "Finance & Markets",
  "published": "2026-10-21T23:50:14.000Z",
  "source": {
    "name": "Investing.com",
    "slug": "investing-com",
    "url": "https://www.investing.com/news/insider-trading-news/jjill-evp-cfo--coo-mark-webb-sells-122600-in-shares-93CH-4964435"
  },
  "original_language": "en",
  "account": "J.Jill Inc., a company listed on the NASDAQ under the ticker symbol JILL, saw its Executive Vice President, Chief Financial Officer, and Chief Operating Officer, Mr. Mark W. Webb, dispose of a sizable portion of his shares on October 19, 2026. He sold 5,000 shares, amounting to a total of $122,600. The price per share ranged between $24.25 and $24.85, with a weighted average price of $24.52 for the transaction.\n\nPost these transactions, Mr. Webb continues to hold 113,523.43 shares of J.Jill common stock directly. The sale of these shares occurred as JILL shares were trading at $23.32, nearing their 52-week high of $25.14. According to InvestingPro Tips, JILL shares have shown a remarkable return over the past year, up by 52%. The company appears to be undervalued based on InvestingPro’s Fair Value analysis.\n\nApart from this insider sale, J.Jill Inc. has recently reported its fiscal second-quarter earnings for 2026, which exceeded market expectations. The company reported an adjusted earnings per share of $1.24, significantly surpassing the expected $0.57, and generated revenue of $154.8 million, surpassing the forecasted $151.26 million. Analysts have taken notice of J.Jill's performance, with investment firms such as Jefferies, BTIG, and TD Cowen raising their price targets for the company to $25, citing the strong second-quarter results. Jefferies maintained a Buy rating, praising J.Jill's progress in product development, marketing, and customer acquisition. BTIG also maintained its Buy rating, emphasizing that J.Jill's return to positive comparable sales was a significant inflection point. While TD Cowen maintained a Hold rating, it increased its price target to $25, acknowledging the encouraging signs of the company's turnaround efforts.",
  "summary": "J.Jill Inc. (NASDAQ:JILL) CFO and COO Mark Webb sold 5,000 shares of the company's common stock on October 19, 2026, totaling $122,600. The transactions occurred at prices ranging from $24.25 to $24.85 per share, with a weighted average price of $24.52. Following the sale, Webb's beneficial ownership of J.Jill common stock is now 113,523.43 shares. Despite this sale, JILL shares are currently trading near their 52-week high of $25.14, and the stock has delivered a 52% return over the past year, according to InvestingPro Tips. Additionally, J.Jill reported strong fiscal second-quarter 2026 earnings, surpassing Wall Street expectations with adjusted earnings per share of $1.24 and revenue of $154.8 million. Analysts at Jefferies, BTIG, and TD Cowen have raised their price targets for the company to $25, citing the company's progress in product, marketing, and customer acquisition.",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 2,
    "also_reported_by": [
      {
        "outlet": "Investing.com",
        "title": "Enliven Therapeutics CFO Hohl sells $231,545 in shares",
        "url": "https://urgent.news/2026/10/21/enliven-therapeutics-cfo-hohl-sells-231-545-in-shares",
        "published": "2026-10-21T22:46:08.000Z"
      }
    ]
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}